BiotechTube
Home/Polku Therapeutics/Adj. Prof. Erik Wallén
AP

Adj. Prof. Erik Wallén

Scientific Co-founder

Polku Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesTauopathies

Polku Therapeutics Pipeline

DrugIndicationPhase
PREP/PP2A Modulator ProgramFrontotemporal Dementia (FTD)Discovery

Leadership Team at Polku Therapeutics

DS
Dr. Simon Bennett
Chief Executive Officer
SS
Sebastian Soidinsalo
Chief Operating Officer
PT
Prof. Timo Myöhänen
Scientific Co-founder
View full Polku Therapeutics profile